Loading...

Scandium Canada Ltd.

SCD.VTSX
Basic Materials
Industrial Materials
$0.14
$0.02(12.000%)
Canadian Market opens in 57h 38m

Scandium Canada Ltd. Fundamental Analysis

Scandium Canada Ltd. (SCD.V) shows weak financial fundamentals with a PE ratio of -20.03, profit margin of 0.00%, and ROE of -10.36%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.22
Current Ratio3.95

Areas of Concern

ROE-10.36%
Operating Margin0.00%
We analyze SCD.V's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 24.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
24.5/100

We analyze SCD.V's fundamental strength across five key dimensions:

Efficiency Score

Weak

SCD.V struggles to generate sufficient returns from assets.

ROA > 10%
-9.45%

Valuation Score

Excellent

SCD.V trades at attractive valuation levels.

PE < 25
-20.03
PEG Ratio < 2
0.22

Growth Score

Weak

SCD.V faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

SCD.V maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
3.95

Profitability Score

Weak

SCD.V struggles to sustain strong margins.

ROE > 15%
-1036.18%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is SCD.V Expensive or Cheap?

P/E Ratio

SCD.V trades at -20.03 times earnings. This suggests potential undervaluation.

-20.03

PEG Ratio

When adjusting for growth, SCD.V's PEG of 0.22 indicates potential undervaluation.

0.22

Price to Book

The market values Scandium Canada Ltd. at 1.97 times its book value. This may indicate undervaluation.

1.97

EV/EBITDA

Enterprise value stands at -68.57 times EBITDA. This is generally considered low.

-68.57

How Well Does SCD.V Make Money?

Net Profit Margin

For every $100 in sales, Scandium Canada Ltd. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-10.36 in profit for every $100 of shareholder equity.

-10.36%

ROA

Scandium Canada Ltd. generates $-9.45 in profit for every $100 in assets, demonstrating efficient asset deployment.

-9.45%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

SCD.V converts -5.73% of its market value into free cash.

-5.73%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-20.03

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.22

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.97

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.95

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.10

vs 25 benchmark

ROA

Return on assets percentage

-0.09

vs 25 benchmark

ROCE

Return on capital employed

-0.11

vs 25 benchmark

How SCD.V Stacks Against Its Sector Peers

MetricSCD.V ValueSector AveragePerformance
P/E Ratio-20.0324.52 Better (Cheaper)
ROE-10.36%848.00% Weak
Net Margin0.00%-109409.00% (disorted) Weak
Debt/Equity0.000.56 Strong (Low Leverage)
Current Ratio3.956.73 Strong Liquidity
ROA-9.45%-6696.00% (disorted) Weak

SCD.V outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Scandium Canada Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Commodity, Value

EPS CAGR

N/A

Industry Style: Cyclical, Commodity, Value

FCF CAGR

N/A

Industry Style: Cyclical, Commodity, Value

Fundamental Analysis FAQ